This bill amends Chapter 5-19.1 of the General Laws entitled "Pharmacies" to allow pharmacists to prescribe and dispense FDA-approved tobacco cessation drug therapies to qualified patients. The bill defines a qualified patient as someone who is at least 18 years old, willing to participate in a structured tobacco cessation program, and has been educated on the symptoms and adverse effects of the prescribed medication. Pharmacists must complete education on tobacco cessation therapy and refer or consult with the patient's primary care provider or another provider if necessary. The bill also requires pharmacists to follow updated guidelines and standards of care and provide notification to the patient's primary care provider within five business days of prescribing a tobacco cessation product. The definition of a qualified patient is subject to adaptation by the board of pharmacy. This bill would take effect upon passage.